(0850–0880) Pediatric Rheumatology – Clinical Poster I: JIA

Sunday, November 13, 2022

9:00 AM – 10:30 AM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

9:00 AM – 10:30 AM Eastern Time

Outcomes of Patients with Juvenile Idiopathic Arthritis Following Failure of Initial Tumor Necrosis Factor Inhibitor Medication in the Childhood Arthritis and Rheumatology Research Alliance Registry
Abstract Poster Presenter: Melissa Mannion, MD – University of Alabama at Birmingham
9:00 AM – 10:30 AM Eastern Time

Responsiveness of Patient-Reported Physical Function Measures in Juvenile Arthritis
Abstract Poster Presenter: Alysha Taxter, MD, MS – Nationwide Children's
9:00 AM – 10:30 AM Eastern Time

Development, Refinement and Weighting of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration
Abstract Poster Presenter: Pamela Weiss – Children's Hospital of Philadelphia
9:00 AM – 10:30 AM Eastern Time

Reliability of MRI Lesions Comprising the Preliminary OMERACT Juvenile Idiopathic Arthritis MRI Score (OMERACT JAMRI-SIJ): What Is the Impact of Systematic Reader Calibration?
Abstract Poster Presenter: Walter P. Maksymowych, MD – University of Alberta
9:00 AM – 10:30 AM Eastern Time

Outcome of Uveitis in Juvenile Idiopathic Arthritis and Spondyloarthritis Patients – a 5-year Follow up Study
Abstract Poster Presenter: Filipe Pinheiro, Sr., MD – Centro Hospitalar Universitário de São João
9:00 AM – 10:30 AM Eastern Time

Change in Short Term Outcomes Following Tolerated Disease Activity Level for Individuals with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Abstract Poster Presenter: Melissa Mannion, MD – University of Alabama at Birmingham
9:00 AM – 10:30 AM Eastern Time

A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)
Abstract Poster Presenter: Lori Tucker, MD – BC Children's Hospital
9:00 AM – 10:30 AM Eastern Time

Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs for Classification in Juvenile Spondyloarthritis
Abstract Poster Presenter: Pamela Weiss – Children's Hospital of Philadelphia
9:00 AM – 10:30 AM Eastern Time

Predicting the Occurrence of Drug-Free Inactive Disease Two Years After Diagnosis of Non-Systemic Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Melissa Mannion, MD – University of Alabama at Birmingham
9:00 AM – 10:30 AM Eastern Time

Systemic Juvenile Idiopathic Arthritis Associated Lung Disease in Europe
Abstract Poster Presenter: Claudia Bracaglia, MD – IRCCS Ospedale Pediatrico Bambino Gesu'
9:00 AM – 10:30 AM Eastern Time

Characteristics of Transitioning JIA Patients: Who Is Arriving on the Adult Rheumatologists’ Doorsteps?
Abstract Poster Presenter: Teresa Semalulu, MD, MPH – McMaster
9:00 AM – 10:30 AM Eastern Time

Incidence of Juvenile Idiopathic Arthritis During the COVID-19 Pandemic: An Analysis of National United States Administrative Claims Data
Abstract Poster Presenter: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
9:00 AM – 10:30 AM Eastern Time

Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: An Analysis of National United States Administrative Claims Data
Abstract Poster Presenter: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
9:00 AM – 10:30 AM Eastern Time

Effect of Glucocorticoids on Patient Reported Outcomes in Patients Started on a Biologic Consensus Treatment Plan for the "First Line Options for Systemic JIA Treatment" (FROST) Study
Abstract Poster Presenter: Karen James, MD, MSc – University of Utah
9:00 AM – 10:30 AM Eastern Time

Baseline Clinical and Laboratory Features of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease (SJIA-LD) Cohort
Abstract Poster Presenter: Esraa Eloseily, MD – Cincinnati Children's Hospital Medical Center
9:00 AM – 10:30 AM Eastern Time

Opioid Use in Youth with Inflammatory Bowel Disease (IBD)-related Arthritis
Abstract Poster Presenter: Atiye Bilgic Dagci, MD – University of Michigan Department of Pediatric Rheumatology
9:00 AM – 10:30 AM Eastern Time

Outcomes of Children with Uveitis Associated with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV) Treated with Methotrexate and Infliximab
Abstract Poster Presenter: Sheila Angeles-Han, MD, MSc – Cincinnati Children's Hospital
9:00 AM – 10:30 AM Eastern Time

Regulatory Haplotype of CXCR4 Is Associated with sJIA and Corelates with Enhanced Neutrophil and CD14+ Monocyte Migration
Abstract Poster Presenter: Hiroto Nakano, MD, PhD – NIAMS, NIH
9:00 AM – 10:30 AM Eastern Time

Spondyloarthritis and Neonatal Factors Affecting the Gut Microbiome
Abstract Poster Presenter: Joy Um, MD – Washington University in St. Louis
9:00 AM – 10:30 AM Eastern Time

Behavioral Health Outcomes and Social Determinants of Health in Children with Juvenile Arthritis Compared to Children with Diabetes and Healthy Children
Abstract Poster Presenter: Francesca Lupini, MS – Children's National Hospital
9:00 AM – 10:30 AM Eastern Time

Knee Acoustic Emissions as a Noninvasive Biomarker of Articular Health in Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Sevda Gharehbaghi, PhD – Georgia Institute of Technology
9:00 AM – 10:30 AM Eastern Time

WITHDRAWN
9:00 AM – 10:30 AM Eastern Time

Incidence, Risk Factors, and Outcomes of Eosinophilia on IL-1 and IL-6 Inhibitors in Systemic and Non-Systemic Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Holly Wobma, MD, PhD – Boston Children's Hospital
9:00 AM – 10:30 AM Eastern Time

Celiac-Associated Arthritis: Clinical Features, Treatment, and Outcomes
Abstract Poster Presenter: Ana Luiza Altaffer, MD – Texas Children's Hospital
9:00 AM – 10:30 AM Eastern Time

A Tale of Many Canadas: Associations of Ethnicity with Juvenile Idiopathic Arthritis Categories and Disease Severity at Presentation in a Multicultural Universal Healthcare Setting: Results from ReACCh-Out
Abstract Poster Presenter: Stephanie Wong, MD – University of British Columbia
9:00 AM – 10:30 AM Eastern Time

Predictive Biomarkers of Tofacitinib Response and Disease Activity in Juvenile Idiopathic Arthritis Subtypes: A Longitudinal Study
Abstract Poster Presenter: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
9:00 AM – 10:30 AM Eastern Time

Investigation of Predictive Factors for Active Disease Status Within 24 Months of Juvenile Idiopathic Arthritis Diagnosis
Abstract Poster Presenter: Erin Balay-Dustrude, MD – University of Washington
9:00 AM – 10:30 AM Eastern Time

Neutrophils Extracellular Traps Formation May Serve as a Biomarker for Disease Activity in Oligoarticular Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Merav Heshin Bekenstein, MD – Tel Aviv Medical Center Israel
9:00 AM – 10:30 AM Eastern Time

A United States Nationwide Analysis of Total Knee Arthroplasty in Patients < 21 Years Old
Abstract Poster Presenter: John Gibbons, BA – Columbia Vagelos College of Physicians and Surgeons
9:00 AM – 10:30 AM Eastern Time

Golimumab for Treatment of Polyarticular Juvenile Idiopathic Arthritis - Safety and Effectiveness Updates from a Comparative Study
Abstract Poster Presenter: Angela Zimmer, MD – Asklepios
9:00 AM – 10:30 AM Eastern Time

Impact of Characteristic Inflammatory and Structural Imaging Lesions on Expert Classification of Axial Juvenile Spondyloarthritis
Abstract Poster Presenter: Adam Mayer, MD – University of Pennsylvania/Children's Hospital of Philadelphia